.

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..

twenty students and two teachers at mt maria college were sent to hospital

. august 29, 2017. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing... ..